Dobutamine 12.5mg/ml Concentrate for solution for infusion Malta - English - Medicines Authority

dobutamine 12.5mg/ml concentrate for solution for infusion

claris lifesciences uk limited - dobutamine - concentrate for solution for infusion - dobutamine 12.5 milligram(s)/millilitre - cardiac therapy

Dobutamine 12.5mg/ml Concentrate for solution for infusion Malta - English - Medicines Authority

dobutamine 12.5mg/ml concentrate for solution for infusion

baxter holding b.v. kobaltweg 49, 3542ce utrecht, netherlands - dobutamine - concentrate for solution for infusion - dobutamine 12.5 mg/ml - cardiac therapy

Dobutamine-Claris dobutamine (as hydrochloride) 250 mg/ 20 mL concentrated solution for injection ampoule Australia - English - Department of Health (Therapeutic Goods Administration)

dobutamine-claris dobutamine (as hydrochloride) 250 mg/ 20 ml concentrated solution for injection ampoule

baxter healthcare pty ltd - dobutamine hydrochloride, quantity: 14.01 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, concentrated - excipient ingredients: sodium metabisulfite; hydrochloric acid; sodium hydroxide; water for injections - adults who require short-term treatment of cardiac failure secondary to acute myocardial infarction, or cardiac surgery.???

DOBUTAMINE PFIZER 12.5 Mg/Ml Concentrate for Soln for Inf Ireland - English - HPRA (Health Products Regulatory Authority)

dobutamine pfizer 12.5 mg/ml concentrate for soln for inf

pfizer healthcare ireland - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml

DOBUTAMINE-HAMELN 250 MG/20 ML AMPOULE 12.5 Mg/Ml Concentrate for Soln for Inf Ireland - English - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/20 ml ampoule 12.5 mg/ml concentrate for soln for inf

hameln pharmaceuticals gmbh - dobutamine hydrochloride - concentrate for soln for inf - 12.5 mg/ml

DOBUTAMINE-HAMELN 250 MG/ 5 ML AMPOULE 50 Mg/Ml Concentrate for Soln for Inf Ireland - English - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/ 5 ml ampoule 50 mg/ml concentrate for soln for inf

hameln pharmaceuticals gmbh - dobutamine hydrochloride - concentrate for soln for inf - 50 mg/ml

DOBUTAMINE-HAMELN 250 MG/ 50 ML VIAL 5 Mg/Ml Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/ 50 ml vial 5 mg/ml solution for infusion

hameln pharmaceuticals gmbh - dobutamine hydrochloride - solution for infusion - 5 mg/ml

DOBUTAMINE-HAMELN 250 MG/50 ML AMPOULE 5 Mg/Ml Solution for Infusion Ireland - English - HPRA (Health Products Regulatory Authority)

dobutamine-hameln 250 mg/50 ml ampoule 5 mg/ml solution for infusion

hameln pharmaceuticals gmbh - dobutamine hydrochloride - solution for infusion - 5 mg/ml

DOBUTAMINE SANDOZ Australia - English - Department of Health (Therapeutic Goods Administration)

dobutamine sandoz

sandoz pty ltd - dobutamine hydrochloride -

Hospira Dobutamine 12.5 mg/mL Sterile Concentrate 250 mg/20 mL vial Australia - English - Department of Health (Therapeutic Goods Administration)

hospira dobutamine 12.5 mg/ml sterile concentrate 250 mg/20 ml vial

hospira australia pty ltd - dobutamine hydrochloride, quantity: 14.01 mg/ml (equivalent: dobutamine, qty 12.5 mg/ml) - injection, concentrated - excipient ingredients: sodium metabisulfite; water for injections; hydrochloric acid; sodium hydroxide - dobutamine is indicated for adults who require inotropic support in the treatment of low output cardiac failure associated with organic heart disease, myocardial infarction, open heart surgery, cardiomyophathies, septic shock and cardiogenic shock. dobutamine can increase or maintain cardiac output during positive end expiratory pressure ventilation.